Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum iCo Therapeutics V.MSCL

Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 
@ the Bell: Energy & mining recover to lift TSX
Following a nasty session in the red, Canada’s main stock index rose more than 300 points in Friday trading. Gains were led by the energy and base metal sectors.After two brutal weeks brought... read article.
The Cannabis Report: June 24, 2022
Nextleaf to launch THC-O as an excise tax-free alternative to Delta-9-THC Nextleaf Solutions (OILS) has provided an update on the manufacturing of D9-tetrahydrocannabinol acetate,... read article.
Buzz on the Bullboards: Another summer of uncertainty?
In times of uncertainty in the markets, investors tend to focus on more consistent plays.Not all investors are basking in summer vacations and backyard barbeques. For those who are still plugged... read article.

New Press Release - Satellos Bioscience Co-Founder and Chief Scientific Officer Dr. Michael Rudnicki Officially Recognized as a Fellow of the Royal Society

Toronto, Ontario--(Newsfile Corp. - June 22, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Corporation"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, is pleased to announce that Co-founder and...read article.

RE:RE:Down again

you're absolutely right... this looks more and more like a big time loser  rate and reply

New Press Release - Satellos Bioscience Co-Founder and Chief Scientific Officer Awarded Prestigious Defeat Duchenne Canada 2022 Grant

Toronto, Ontario--(Newsfile Corp. - June 17, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, announced today that Co-founder and Chief...read article.

RE:Down again

and again..investors just wanting out at this point.. kicking myself for not exiting when we had that last bump to 1.20. It really seems like satellos has nothing going on other than hopes and dreams....read more

Down again

Down .02 on volume guess we don't need your update Frankie boy!  Waste of time and money Frankie boy hope you got lucky and shipfaced, least us shareholders could do for you. Lol  rate and reply

LD Micro Invatational

  Hey Frankie boy did you enjoy your paid vacation at your June 7 [ that was 3 days ago and we the shareholders have heard nothing? ] presentation?  CAN HARDLY WAIT TO HEAR ALL THE GOOD...read more

RE:.0325

absolutely brutal.. "nasdaq listing this year" laughable... don't worry I'm sure there will be some more big news about another conference they are going to.  rate and reply

.0325

Pre-consolidation price nice job BND over and management bonuses all around.  You guys all should be in jail.   rate and reply

Hey “BND” overt

.65 you still collecting your $10,000 a month? What a fn joke this company and directors are.  rate and reply

MSCL Hiccup .85

LOL  rate and reply

MSCL HUP 1.10

eom  rate and reply

Sleeping pills

  So if I'm correct in a year from now we may have a "cbd" based sleeping pill.  Hopefully I won't lose any sleep waiting for this leading edge technology LOL WAFJ.   rate and reply

Some Hope?

Satellos Bioscience Provides Update on Joint Development Initiative with NW PharmaTech Limited NewsfileMar 11, 2022 7:00 AM EST ...read more

RE:RE:Hey BND “over”

no kidding... what a joke, they shelved ICO assets and now we have to wait many years for this to move... if ever will move! Complete rip-off  rate and reply

RE:Hey BND “over”

We are now sitting at a $0 .0325 pre-consolidation share price level. G1945V  rate and reply

Hey BND “over”

  Well done we should yay .09 by summer's end, keep up the good work and maybe you can ask for more monies at the next AGM.     rate and reply

Interview Recap w Radius Research & $MSCL CEO Frank Gleeson

Video Recap: Satellos Bioscience (MSCL) w CEO Frank Gleeson - Rebuilding Muscle From Within - Deep Dive, Interview and Q&A - https://www.youtube.com/watch?v=dReAJsXyJm0 {^youtubevideo...read more

RE:RE:ico is a burn barrel......period

No interest in the webinar? Nothing being said to give us hope? I didn't! Wasn't interested in listening to something that I really don't understand! What I am interested in is the...read more

RE:ico is a burn barrel......period

yeap... I'm for sure dumping more of my money let's see if it's burn or bloom... I think it's more like kaboom!  rate and reply

ico is a burn barrel......period

dump all your money in it and  let the incinerator do work it s a dump and flush stock since i  can remeber 2016  rate and reply